Moran Wealth Management LLC Sells 6,182 Shares of CME Group Inc. $CME

Moran Wealth Management LLC lowered its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 7.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 77,114 shares of the financial services provider’s stock after selling 6,182 shares during the quarter. Moran Wealth Management LLC’s holdings in CME Group were worth $21,254,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of CME Group by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider’s stock worth $9,190,661,000 after acquiring an additional 400,737 shares in the last quarter. Raymond James Financial Inc. raised its stake in shares of CME Group by 9.7% during the 1st quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider’s stock worth $1,091,401,000 after acquiring an additional 363,130 shares in the last quarter. Vontobel Holding Ltd. raised its stake in shares of CME Group by 3.0% during the 2nd quarter. Vontobel Holding Ltd. now owns 2,920,046 shares of the financial services provider’s stock worth $804,823,000 after acquiring an additional 84,005 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of CME Group by 29.9% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider’s stock worth $747,744,000 after acquiring an additional 648,591 shares in the last quarter. Finally, AQR Capital Management LLC raised its stake in shares of CME Group by 10.3% during the 1st quarter. AQR Capital Management LLC now owns 2,783,759 shares of the financial services provider’s stock worth $735,539,000 after acquiring an additional 260,065 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In related news, insider Timothy Francis Mccourt sold 379 shares of the stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the sale, the insider directly owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director William R. Shepard purchased 262 shares of the stock in a transaction that occurred on Thursday, September 25th. The shares were purchased at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the acquisition, the director directly owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This represents a 0.10% increase in their position. The disclosure for this purchase can be found here. Insiders have sold 13,043 shares of company stock worth $3,527,956 over the last ninety days. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts recently commented on CME shares. Piper Sandler boosted their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 15th. Raymond James Financial reduced their price objective on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research note on Monday. Morgan Stanley upped their price target on shares of CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a research note on Wednesday, October 1st. Oppenheimer upped their price target on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on shares of CME Group from $276.00 to $266.00 and set a “hold” rating on the stock in a research note on Thursday, October 9th. Seven equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $283.43.

Read Our Latest Research Report on CME

CME Group Stock Down 0.1%

NASDAQ:CME opened at $271.28 on Tuesday. The firm has a market capitalization of $97.76 billion, a P/E ratio of 26.26, a PEG ratio of 5.72 and a beta of 0.41. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79. The company’s fifty day moving average price is $268.57 and its 200-day moving average price is $271.35. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.56 earnings per share. As a group, equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a $1.25 dividend. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s dividend payout ratio is presently 48.40%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.